Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Bulk Density Testing for Granules – V 2.0

Posted on By

Tablets: SOP for Bulk Density Testing for Granules – V 2.0

Standard Operating Procedure for Bulk Density Testing for Granules

Department Quality Control
SOP No. SOP/TAB/112/2025
Supersedes SOP/TAB/112/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for performing bulk density testing of granules used in tablet formulations, ensuring that the granules meet the required specifications for quality and consistency.

2. Scope

This SOP applies to the testing of bulk density of granules, which is an important parameter to assess the flowability and compressibility of the granules in tablet manufacturing.

3. Responsibilities

  • Quality Control (QC): Responsible for conducting bulk density testing on granules and ensuring that the results comply with specifications.
  • Quality Assurance (QA): Reviews and approves the results from bulk density testing and ensures the testing is performed according to this SOP.
  • Laboratory Personnel: Responsible for carrying out the bulk density testing according to the method specified, recording data, and reporting results.

4. Accountability

The QC Manager is accountable for ensuring that bulk density testing is performed accurately, and the results meet the quality standards. The QA Manager is responsible for reviewing the results and ensuring compliance with regulatory

standards.

See also  Tablets: SOP for Fluidized Bed Granulation Methodology - V 2.0

5. Procedure

5.1 Sample Preparation

  1. Weigh approximately 50-100 g of granules for bulk density testing, ensuring a homogeneous sample.
  2. Transfer the granules into a clean, dry graduated cylinder or container with known volume (typically 100 mL or 250 mL).
  3. Ensure there is no moisture or dust contamination in the sample container.

5.2 Performing the Bulk Density Test

  1. Tap the graduated cylinder gently on a flat surface or use a tapping apparatus for consistent tapping (e.g., 100 taps) to settle the granules.
  2. Record the final volume of the granules after tapping, ensuring it is stable and consistent.
  3. Calculate the bulk density using the following formula:
    • Bulk Density (g/mL) = Mass of the sample (g) / Volume of the granules (mL)

5.3 Repeat Testing

  1. Repeat the bulk density testing for a minimum of three different samples from the same batch to ensure reproducibility of the results.
  2. Ensure that all samples are tested under the same conditions and using the same volume measurement method.

5.4 Data Analysis and Calculation

  1. Calculate the average bulk density from the three measurements and report the final value.
  2. If any measurement deviates significantly (more than ±5%) from the others, investigate and perform re-testing.
See also  Tablets: SOP for X-Ray Powder Diffraction for API Analysis in Tablets - V 2.0

5.5 Acceptance Criteria

  1. The bulk density of the granules should fall within the predefined limits based on the formulation’s requirements (e.g., 0.5–1.0 g/mL for most tablet formulations).
  2. If the bulk density falls outside the acceptable range, investigate potential causes such as particle size distribution, moisture content, or compaction issues in the granulation process.
  3. Document any deviations and corrective actions taken (Annexure-1).

5.6 Documentation and Record-Keeping

  1. Record all bulk density test results, including the mass, volume measurements, and final bulk density calculations, in the batch record (Annexure-2).
  2. Ensure that all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.
  3. Maintain raw data, including weighing logs and any additional testing results, for regulatory compliance and future reference.

5.7 Post-Test Actions

  1. Clean the graduated cylinders or containers used for bulk density testing to remove any residual granules or powder.
  2. Dispose of used samples, solvents, and reagents according to the company’s waste disposal procedures.
  3. Ensure that laboratory instruments are maintained and calibrated according to the instrument SOP.

See also  Tablets: SOP for Moisture Control During Granule Drying - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • g/mL: Grams per Milliliter

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <616> – Granulation and Powder Flowability
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Specifications for Granule Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Bulk density outside acceptable range Adjusted granulation process and re-tested John Doe

Annexure-2: Batch Record

Batch Number Sample Weight (g) Volume (mL) Bulk Density (g/mL) Result
Batch 001 100 g 150 mL 0.67 g/mL Pass

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Acceptance Criteria Improved granule flowability requirements QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Decontamination Procedures for Contaminated Quarantine Raw Materials – V 2.0
Next Post: Creams: SOP for Handling Excipient Dispensing in Cream Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version